Research programme: small molecules - Zosano Pharma

Drug Profile

Research programme: small molecules - Zosano Pharma

Alternative Names: Epinephrine transdermal - Zosano Pharma; Fentanyl - Zosano Pharma; Granisetron - Zosano Pharma; Naratriptan - Zosano Pharma; Pentosan polysulfate - Zosano Pharma; Sumatriptan - Zosano Pharma; Zolmitriptan - Zosano Pharma

Latest Information Update: 02 Sep 2016

Price : $50

At a glance

  • Originator Zosano Pharma
  • Class Small molecules
  • Mechanism of Action Adrenergic receptor agonists; Cell membrane structure inhibitors; Opioid mu receptor agonists; Serotonin 1 receptor agonists; Serotonin 1B receptor agonists; Serotonin 1D receptor agonists; Serotonin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Anaphylaxis; Chemotherapy-induced nausea and vomiting; Interstitial cystitis; Migraine; Pain; Thrombosis

Most Recent Events

  • 29 Sep 2015 Preclinical trials in Thrombosis in USA (Transdermal)
  • 29 Sep 2015 Preclinical trials in Pain in USA (Transdermal)
  • 29 Sep 2015 Preclinical trials in Migraine in USA (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top